Circular zymogens of human ribonuclease 1.


Journal

Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750

Informations de publication

Date de publication:
09 2019
Historique:
received: 07 06 2019
revised: 11 07 2019
accepted: 11 07 2019
pubmed: 16 7 2019
medline: 6 5 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

The endogenous production of enzymes as zymogens provides a means to control catalytic activities. Here, we describe the heterologous production of ribonuclease 1 (RNase 1), which is the most prevalent secretory ribonuclease in humans, as a zymogen. In folded RNase 1, the N and C termini flank the enzymic active site. By using intein-mediated cis-splicing, we created circular proteins in which access to the active site of RNase 1 is obstructed by an amino-acid sequence that is recognized by the HIV-1 protease. Installing a sequence that does not perturb the RNase 1 fold led to only modest inactivation. In contrast, the ancillary truncation of residues from each terminus led to a substantial decrease in the catalytic activity of the zymogen with the maintenance of thermostability. For optimized zymogens, activation by HIV-1 protease led to a > 10

Identifiants

pubmed: 31306518
doi: 10.1002/pro.3686
pmc: PMC6699097
doi:

Substances chimiques

Enzyme Precursors 0
Ribonuclease, Pancreatic EC 3.1.27.5
HIV Protease EC 3.4.23.-
p16 protease, Human immunodeficiency virus 1 EC 3.4.23.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1713-1719

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM008349
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM044783
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA073808
Pays : United States

Informations de copyright

© 2019 The Protein Society.

Références

PLoS One. 2011;6(8):e23294
pubmed: 21887241
Virology. 2000 Sep 1;274(2):391-401
pubmed: 10964781
FEBS J. 2006 Dec;273(23):5457-65
pubmed: 17116245
AIDS Res Hum Retroviruses. 2008 Nov;24(11):1357-63
pubmed: 19025416
J Biol Chem. 1994 Aug 26;269(34):21526-31
pubmed: 8063789
Eur J Biochem. 1997 Apr 15;245(2):465-9
pubmed: 9151980
Nucleic Acids Res. 1999 Sep 15;27(18):3696-701
pubmed: 10471739
Assay Drug Dev Technol. 2012 Apr;10(2):128-36
pubmed: 22066913
Acta Crystallogr D Struct Biol. 2018 Jul 1;74(Pt 7):690-694
pubmed: 29968678
FEBS Lett. 1991 Apr 9;281(1-2):77-80
pubmed: 2015912
J Biol Chem. 2014 Sep 19;289(38):25996-6006
pubmed: 25078100
FEBS J. 2011 Oct;278(19):3633-43
pubmed: 21824291
J Mol Biol. 2007 Oct 19;373(2):503-19
pubmed: 17825317
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10034-9
pubmed: 8816746
J Biol Chem. 2001 Nov 16;276(46):43095-102
pubmed: 11555655
PLoS One. 2013;8(1):e54568
pubmed: 23349931
Nat Struct Biol. 2003 Feb;10(2):115-9
pubmed: 12496934
Cell Death Differ. 1999 Nov;6(11):1081-6
pubmed: 10578177
ACS Chem Biol. 2019 Apr 19;14(4):599-602
pubmed: 30830748
Methods Enzymol. 2012;502:273-90
pubmed: 22208989
Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):498-505
pubmed: 11264578
J Chem Theory Comput. 2015 Feb 10;11(2):609-22
pubmed: 25866491
Angew Chem Int Ed Engl. 2011 Jul 11;50(29):6511-5
pubmed: 21656885
J Thromb Haemost. 2011 Jul;9 Suppl 1:26-34
pubmed: 21781239
Biochemistry. 1998 Sep 1;37(35):12121-32
pubmed: 9724524
Nat Med. 1999 Jan;5(1):29-33
pubmed: 9883836
PLoS One. 2013 May 21;8(5):e63090
pubmed: 23704889
J Mol Biol. 2007 Apr 27;368(2):434-49
pubmed: 17350650
Sci Rep. 2015 Aug 11;5:11286
pubmed: 26261098
Protein Sci. 2019 Sep;28(9):1713-1719
pubmed: 31306518
FEBS Lett. 2009 Mar 4;583(5):909-14
pubmed: 19302791
Prog Nucleic Acid Res Mol Biol. 2005;80:349-74
pubmed: 16164979
Biochemistry. 2009 Apr 21;48(15):3497-507
pubmed: 19260676
J Biol Chem. 2000 Mar 31;275(13):9091-4
pubmed: 10734038
Curr Pharm Biotechnol. 2008 Jun;9(3):185-9
pubmed: 18673284
J Biochem. 2002 Feb;131(2):193-200
pubmed: 11820931
Angew Chem Int Ed Engl. 2007;46(40):7595-9
pubmed: 17722214
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495

Auteurs

Ian W Windsor (IW)

Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin.
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Crystal J Graff (CJ)

Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin.

Ronald T Raines (RT)

Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin.
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH